While Pharmaceutical giant Bayer is still on track to buy Monsanto in what is slated to be one of the year’s biggest buyouts, it appears the deal has slowed down dramatically. A report by Reuters says that:
German drugs and pesticides group Bayer (BAYGn.DE) said on Tuesday it was now likely to be early next year before it can complete its $66 billion deal to acquire U.S. group Monsanto (MON.N), later than previously expected.
This snag, however, may start to worry investors. The complication are the result of the EU taking more time to review the impact the merger will have on the market:
More broadly, it said the deal might slow the race to develop new products, and that the European Union would try to prevent Bayer from becoming too dominant in combined offerings of seeds and pesticides with the help of digital farming tools such as connected sensors, software and precision machines.
Investors should follow the situation closely as the deal may be amended to fit in with Europe’s tough criteria. To stay up to date, be sure to sign up for our free newsletter down below. To read the full story, go to reuters.com.
[grwebform url=”https://app.getresponse.com/view_webform_v2.js?u=BKTzq&webforms_id=14431602″ css=”on” center=”off” center_margin=”200″/]
You may be interested
Job Hiring is Picking Up as Employers and Consumers Gain ConfidenceLamont J - March 29, 2021
The recent government stimulus for small and medium-sized businesses, personal stimulus checks, and declining Coronavirus cases, are all great news…
Fed Could Maintain 0% Interest Rate Until 2024Adam R - March 26, 2021
The Federal Reserve is holding its target interest rate in a range of 0.00% - 0.25%, even while the economy…